First Nonprescription Birth Control Pill Approved For Marketing By FDA: A Milestone For Reproductive Health
As we previously reported, Perrigo Company's subsidiary HRA Pharma submitted an application to the Food and Drug Administration in the summer of 2022 to switch an existing prescription-only...